BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12703198)

  • 1. Thymidylate synthase inhibitors.
    Ackland SP; Clarke SJ; Beale P; Peters GJ
    Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
    [No Abstract]   [Full Text] [Related]  

  • 2. Thymidylate synthase inhibitors.
    Ismail AS; Grem JL
    Cancer Chemother Biol Response Modif; 2001; 19():1-19. PubMed ID: 11686010
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymidylate synthase inhibitors in colorectal cancer.
    Cassidy J
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):83-7. PubMed ID: 11049037
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials referral resource. Clinical trials with tomudex.
    Sorensen JM; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 Jul; 10(7):1041-2. PubMed ID: 8837120
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymidylate synthase inhibitors.
    Ackland SP; Beale P; Peters GJ
    Cancer Chemother Biol Response Modif; 2003; 21():1-28. PubMed ID: 15338738
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifolates: the next millennium.
    Allegra CJ
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-2. PubMed ID: 10598548
    [No Abstract]   [Full Text] [Related]  

  • 7. MTA, a novel multitargeted antifolate, from preclinical to phase I and beyond: summary and conclusions.
    Calvert H
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):105-8. PubMed ID: 10598564
    [No Abstract]   [Full Text] [Related]  

  • 8. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
    Chu E; Callender MA; Farrell MP; Schmitz JC
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
    Calvert H
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
    [No Abstract]   [Full Text] [Related]  

  • 10. Raltitrexed, a novel folate-based thymidylate synthase inhibitor, for the treatment of acute leukemia: is this drug active against acute myelogenous leukemia?
    Takemura Y; Kobayashi H; Miyachi H
    Int J Hematol; 2000 Jul; 72(1):112-4. PubMed ID: 10979221
    [No Abstract]   [Full Text] [Related]  

  • 11. Thymidylate synthase inhibitors.
    Takimoto CH; Diggikar S
    Cancer Chemother Biol Response Modif; 2005; 22():1-18. PubMed ID: 16110605
    [No Abstract]   [Full Text] [Related]  

  • 12. Positioning pemetrexed in the treatment of ovarian cancer.
    Ledermann JA; Stebbing J
    Eur J Cancer; 2009 May; 45(8):1330-2. PubMed ID: 19264477
    [No Abstract]   [Full Text] [Related]  

  • 13. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oxaliplatin: perspectives and future developments].
    Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
    Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
    [No Abstract]   [Full Text] [Related]  

  • 15. Future potential of thymidylate synthase inhibitors in cancer therapy.
    Lehman NL
    Expert Opin Investig Drugs; 2002 Dec; 11(12):1775-87. PubMed ID: 12457437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of thymidylate synthase and glycinamide ribonucleotide transformylase.
    Jackson RC
    Adv Exp Med Biol; 1994; 370():179-83. PubMed ID: 7660885
    [No Abstract]   [Full Text] [Related]  

  • 17. The renewed potential for folate antagonists in contemporary cancer chemotherapy.
    Berman EM; Werbel LM
    J Med Chem; 1991 Feb; 34(2):479-85. PubMed ID: 1995868
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymidylate synthase structure, function and implication in drug discovery.
    Costi MP; Ferrari S; Venturelli A; Calò S; Tondi D; Barlocco D
    Curr Med Chem; 2005; 12(19):2241-58. PubMed ID: 16178783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.
    Fernandes DJ; Bertino JR; Hynes JB
    Cancer Res; 1983 Mar; 43(3):1117-23. PubMed ID: 6825083
    [No Abstract]   [Full Text] [Related]  

  • 20. New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: Thymidylate synthase.
    van der Wilt CL; Peters GJ
    Pharm World Sci; 1994 Apr; 16(2):84-103. PubMed ID: 7518280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.